BCM
TVGN icon

Beryl Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Beryl Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,181
Closed -$6.58M – 70
2022
Q1 		$6.58M Buy
+13,181
New +$6.55M 0.4% 96

Other funds holding TVGN

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Beryl Capital Management's TVGN Position: Q2 2022 in Review

Beryl Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q2 2022, closing a stake of 13,181 shares — an estimated $6.58M sold.

Beryl Capital Management first reported a position in TVGN in Q1 2022 and held it in 1 quarter. The position peaked at $6.58M in Q1 2022. 67 funds tracked by Wall St. Rank hold TVGN as of Q2 2022.

  • Beryl Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Beryl Capital Management sold 13,181 Tevogen Inc. Common Stock shares in Q2 2022, an estimated $6.58M.
  • Beryl Capital Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Beryl Capital Management's Tevogen Inc. Common Stock position peaked at $6.58M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q2 2022.

Based on Beryl Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.